Company Profile

AmideBio LLC
Profile last edited on: 10/11/2022      CAGE: 5NBN2      UEI: UN9KNR7J6J77

Business Identifier: Peptide research reagents and clinical products for clinical and therapeutic marketplaces: novel peptides targeting metabolic disease.
Year Founded
2009
First Award
2017
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

331 South 104th Street Uni 110
Louisville, CO 80027
   (303) 604-0296
   info@amidebio.com
   www.amidebio.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

Structured around discovery and development of novel peptides for treatment of metabolic diseases, AmideBio leverages its proprietary BioPureĀ™ peptide manufacturing technology to supply ultrapure peptides for research purposes. A biotech company having created their BioPure platform technology to manufacture peptides and proteins, the focus is on therapeutic targets and diagnostics invvolving diabetes, and neurodegenerative diseases and has generated a series of different types of insulins to improve stability issues that limit the growth of existing insulin. The BioPure platform supports production of proinsulin, toxins, boowman-birk inhibitors and several other crucial peptides. The company also produces amyloids for Alzheimer's research.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $4,588,524
Project Title: Stable Glucagon for Treatment of Hyperinsulinism
2022 2 NIH $300,000
Project Title: Novel Glucose Responsive Insulin for Improved Treatment of Diabetes

Key People / Management

  Stephen P Eisenberg -- Product Development Director

  Pawel Fludzinski

  Yanyu Peng -- Product Development Manager

  Elizabeth Schanuel -- Product Development Technician

  Michael H B Stowell -- CTO and Founder

Company News

There are no news available.